$1 BillionGenentechCollaborationTargetedTherapeutic(Asset)FinancingTurn-KeyFacilitiesEntrepreneursHarvardMedicalSchoolPetraPharmaOperatingPartners?MDAndersonCancerCenterOncologyTemasekCPRIT2.85DVPILodoTherapeuticsBruceL.A.Carter,Ph.D.EliLillyAbbvie2014 Top-quartileRankedSeattleOfficeEmployeesWRFCapitalPronirasExceptionalTrackRecordCorporateSpinoutsUTSouthwesternMedicalCenterPennStateARCHVenturePartnersRodeoTherapeuticsApogenBiotechnologiesSundarKodiyalamWuXiPharmaTechGatesFoundationStrategicPartnershipsTop-tierInvestorsAlexandriaVentureInvestmentsUniversityofMinnesotaReviewed >4,000OpportunitiesTheRockefellerUniversity$3.375BillionExitDiversity(BARDA)– onupdatedslide deckSanDiegoOfficeAcademic&ResearchInstitutionsCaseWesternReserveLydianNeurosciencesNewYorkOfficeAdvisory&CorporateBoardsUniformedServicesUniversityScientists&TechnologyDevelopersNeuroscience& NeurologyDanaFarberCancerCSABMembers?$12.3MillionNIDAGrantAI &MachineLearningSubstantialExitHistoryJanLundberg,Ph.D.GeneYeo,Ph.D.1.02DPISingaporeOfficeLeroyHood,M.D.,Ph.D.PfizerVenturesSyndicationPartnersColumbiaUniversityWeillCornellMedicine58.43%IRRDivestitures150+Years’ExperienceTachiYamada,M.D.Capital-efficiencyNon-DilutiveFundingMagnoliaNeurosciencesScientificExpertiseSteveGillis,Ph.D.$1 BillionGenentechCollaborationTargetedTherapeutic(Asset)FinancingTurn-KeyFacilitiesEntrepreneursHarvardMedicalSchoolPetraPharmaOperatingPartners?MDAndersonCancerCenterOncologyTemasekCPRIT2.85DVPILodoTherapeuticsBruceL.A.Carter,Ph.D.EliLillyAbbvie2014 Top-quartileRankedSeattleOfficeEmployeesWRFCapitalPronirasExceptionalTrackRecordCorporateSpinoutsUTSouthwesternMedicalCenterPennStateARCHVenturePartnersRodeoTherapeuticsApogenBiotechnologiesSundarKodiyalamWuXiPharmaTechGatesFoundationStrategicPartnershipsTop-tierInvestorsAlexandriaVentureInvestmentsUniversityofMinnesotaReviewed >4,000OpportunitiesTheRockefellerUniversity$3.375BillionExitDiversity(BARDA)– onupdatedslide deckSanDiegoOfficeAcademic&ResearchInstitutionsCaseWesternReserveLydianNeurosciencesNewYorkOfficeAdvisory&CorporateBoardsUniformedServicesUniversityScientists&TechnologyDevelopersNeuroscience& NeurologyDanaFarberCancerCSABMembers?$12.3MillionNIDAGrantAI &MachineLearningSubstantialExitHistoryJanLundberg,Ph.D.GeneYeo,Ph.D.1.02DPISingaporeOfficeLeroyHood,M.D.,Ph.D.PfizerVenturesSyndicationPartnersColumbiaUniversityWeillCornellMedicine58.43%IRRDivestitures150+Years’ExperienceTachiYamada,M.D.Capital-efficiencyNon-DilutiveFundingMagnoliaNeurosciencesScientificExpertiseSteveGillis,Ph.D.

Untitled Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
O
2
O
3
G
4
I
5
N
6
N
7
I
8
I
9
I
10
O
11
N
12
B
13
I
14
N
15
G
16
I
17
O
18
O
19
I
20
N
21
B
22
I
23
G
24
G
25
N
26
O
27
O
28
G
29
B
30
G
31
B
32
G
33
B
34
B
35
B
36
B
37
N
38
G
39
N
40
B
41
B
42
B
43
I
44
N
45
G
46
I
47
G
48
N
49
N
50
I
51
B
52
O
53
G
54
I
55
G
56
I
57
O
58
N
59
O
60
I
61
N
62
O
63
B
64
G
65
O
66
B
67
O
68
B
69
O
70
I
71
N
72
G
  1. O-$1 Billion Genentech Collaboration
  2. O-Targeted Therapeutic (Asset) Financing
  3. G-Turn-Key Facilities
  4. I-Entrepreneurs
  5. N-Harvard Medical School
  6. N-Petra Pharma
  7. I-Operating Partners?
  8. I-MD Anderson Cancer Center
  9. I-Oncology
  10. O-Temasek
  11. N-CPRIT
  12. B-2.85 DVPI
  13. I-Lodo Therapeutics
  14. N-Bruce L.A. Carter, Ph.D.
  15. G-Eli Lilly
  16. I-Abbvie
  17. O-2014 Top-quartile Ranked
  18. O-Seattle Office
  19. I-Employees
  20. N-WRF Capital
  21. B-Proniras
  22. I-Exceptional Track Record
  23. G-Corporate Spinouts
  24. G-UT Southwestern Medical Center
  25. N-Penn State
  26. O-ARCH Venture Partners
  27. O-Rodeo Therapeutics
  28. G-Apogen Biotechnologies
  29. B-Sundar Kodiyalam
  30. G-WuXi PharmaTech
  31. B-Gates Foundation
  32. G-Strategic Partnerships
  33. B-Top-tier Investors
  34. B-Alexandria Venture Investments
  35. B-University of Minnesota
  36. B-Reviewed > 4,000 Opportunities
  37. N-The Rockefeller University
  38. G-$3.375 Billion Exit
  39. N-Diversity
  40. B-(BARDA) – on updated slide deck
  41. B-San Diego Office
  42. B-Academic & Research Institutions
  43. I-Case Western Reserve
  44. N-Lydian Neurosciences
  45. G-New York Office
  46. I-Advisory & Corporate Boards
  47. G-Uniformed Services University
  48. N-Scientists & Technology Developers
  49. N-Neuroscience & Neurology
  50. I-Dana Farber Cancer
  51. B-CSAB Members?
  52. O-$12.3 Million NIDA Grant
  53. G-AI & Machine Learning
  54. I-Substantial Exit History
  55. G-Jan Lundberg, Ph.D.
  56. I-Gene Yeo, Ph.D.
  57. O-1.02 DPI
  58. N-Singapore Office
  59. O-Leroy Hood, M.D., Ph.D.
  60. I-Pfizer Ventures
  61. N-Syndication Partners
  62. O-Columbia University
  63. B-Weill Cornell Medicine
  64. G-58.43% IRR
  65. O-Divestitures
  66. B-150+ Years’ Experience
  67. O-Tachi Yamada, M.D.
  68. B-Capital-efficiency
  69. O-Non-Dilutive Funding
  70. I-Magnolia Neurosciences
  71. N-Scientific Expertise
  72. G-Steve Gillis, Ph.D.